(Total Views: 711)
Posted On: 11/16/2021 10:53:53 AM
Post# of 72441
The CRO is doing/has completed all the data collection and collating of the secondary endpoints and should publish same by end of month.
IMO the main positives for B from the trial should come from the Compassionate Use data but who does all the testing to get secondary endpoints here in regards to viral load reduction, positive signs of reduction of all the other factors that affect organ damage and the like, and who do they send data to other than IPIX?
Would the hospitals run up the blood work for all critical patients given the high dosage of B (I would assume so) and they would submit such data to IPIX so IPIX has backup for any PR they publish regarding same?
IMO the main positives for B from the trial should come from the Compassionate Use data but who does all the testing to get secondary endpoints here in regards to viral load reduction, positive signs of reduction of all the other factors that affect organ damage and the like, and who do they send data to other than IPIX?
Would the hospitals run up the blood work for all critical patients given the high dosage of B (I would assume so) and they would submit such data to IPIX so IPIX has backup for any PR they publish regarding same?
(3)
(0)Scroll down for more posts ▼
